These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 34274415)
21. FTY720 Induces Autophagy-Associated Apoptosis in Human Oral Squamous Carcinoma Cells, in Part, through a Reactive Oxygen Species/Mcl-1-Dependent Mechanism. Bai LY; Chiu CF; Chiu SJ; Chu PC; Weng JR Sci Rep; 2017 Jul; 7(1):5600. PubMed ID: 28717222 [TBL] [Abstract][Full Text] [Related]
22. Combinatorial Effect of Cold Atmosphere Plasma (CAP) and the Anticancer Drug Cisplatin on Oral Squamous Cell Cancer Therapy. Lee CM; Jeong YI; Kook MS; Kim BH Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076565 [TBL] [Abstract][Full Text] [Related]
23. Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell Carcinoma. Suenaga N; Kuramitsu M; Komure K; Kanemaru A; Takano K; Ozeki K; Nishimura Y; Yoshida R; Nakayama H; Shinriki S; Saito H; Jono H Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635163 [TBL] [Abstract][Full Text] [Related]
24. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD. Chen Y; Ke G; Han D; Liang S; Yang G; Wu X Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997 [TBL] [Abstract][Full Text] [Related]
25. Suppression of chloride channel 3 expression facilitates sensitivity of human glioma U251 cells to cisplatin through concomitant inhibition of Akt and autophagy. Su J; Xu Y; Zhou L; Yu HM; Kang JS; Liu N; Quan CS; Sun LK Anat Rec (Hoboken); 2013 Apr; 296(4):595-603. PubMed ID: 23408563 [TBL] [Abstract][Full Text] [Related]
26. Reversal of cisplatin resistance in oral squamous cell carcinoma by piperlongumine loaded smart nanoparticles through inhibition of Hippo-YAP signaling pathway. Sa P; Singh P; Panda S; Swain RK; Dash R; Sahoo SK Transl Res; 2024 Jun; 268():63-78. PubMed ID: 38499286 [TBL] [Abstract][Full Text] [Related]
27. Supramolecular nanodrug targeting CDK4/6 overcomes BAG1 mediated cisplatin resistance in oral squamous cell carcinoma. Zhao B; Qin X; Fu R; Yang M; Hu X; Zhao S; Cui Y; Guo Q; Zhou W J Control Release; 2024 Apr; 368():623-636. PubMed ID: 38479445 [TBL] [Abstract][Full Text] [Related]
28. Naringenin induces endoplasmic reticulum stress-mediated cell apoptosis and autophagy in human oral squamous cell carcinoma cells. Liu JF; Chang TM; Chen PH; Lin JS; Tsai YJ; Wu HM; Lee CJ J Food Biochem; 2022 Nov; 46(11):e14221. PubMed ID: 35596593 [TBL] [Abstract][Full Text] [Related]
29. miR-23a promotes cisplatin chemoresistance and protects against cisplatin-induced apoptosis in tongue squamous cell carcinoma cells through Twist. Peng F; Zhang H; Du Y; Tan P Oncol Rep; 2015 Feb; 33(2):942-50. PubMed ID: 25501015 [TBL] [Abstract][Full Text] [Related]
30. Bitter melon derived extracellular vesicles enhance the therapeutic effects and reduce the drug resistance of 5-fluorouracil on oral squamous cell carcinoma. Yang M; Luo Q; Chen X; Chen F J Nanobiotechnology; 2021 Aug; 19(1):259. PubMed ID: 34454534 [TBL] [Abstract][Full Text] [Related]
31. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma. Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493 [TBL] [Abstract][Full Text] [Related]
32. STAT3- and GSK3β-mediated Mcl-1 regulation modulates TPF resistance in oral squamous cell carcinoma. Maji S; Shriwas O; Samal SK; Priyadarshini M; Rath R; Panda S; Das Majumdar SK; Muduly DK; Dash R Carcinogenesis; 2019 Mar; 40(1):173-183. PubMed ID: 30395230 [TBL] [Abstract][Full Text] [Related]
34. Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy. He J; Yu JJ; Xu Q; Wang L; Zheng JZ; Liu LZ; Jiang BH Autophagy; 2015; 11(2):373-84. PubMed ID: 25650716 [TBL] [Abstract][Full Text] [Related]
35. Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal cancer cells with acquired drug resistance. Yu L; Gu C; Zhong D; Shi L; Kong Y; Zhou Z; Liu S Cancer Lett; 2014 Dec; 355(1):34-45. PubMed ID: 25236911 [TBL] [Abstract][Full Text] [Related]
36. AdoMet triggers apoptosis in head and neck squamous cancer by inducing ER stress and potentiates cell sensitivity to cisplatin. Mosca L; Pagano M; Ilisso CP; Cave DD; Desiderio V; Mele L; Caraglia M; Cacciapuoti G; Porcelli M J Cell Physiol; 2019 Aug; 234(8):13277-13291. PubMed ID: 30575033 [TBL] [Abstract][Full Text] [Related]
37. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression. Wang X; Li H; Shi J Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988 [TBL] [Abstract][Full Text] [Related]
38. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy. Zhang XY; Zhang M; Cong Q; Zhang MX; Zhang MY; Lu YY; Xu CJ Int J Biochem Cell Biol; 2018 Feb; 95():9-16. PubMed ID: 29247711 [TBL] [Abstract][Full Text] [Related]
39. Receptor for advanced glycation end product blockade enhances the chemotherapeutic effect of cisplatin in tongue squamous cell carcinoma by reducing autophagy and modulating the Wnt pathway. Zhao Z; Wang H; Zhang L; Mei X; Hu J; Huang K Anticancer Drugs; 2017 Feb; 28(2):187-196. PubMed ID: 27831944 [TBL] [Abstract][Full Text] [Related]
40. Influence of nonprotective autophagy and the autophagic switch on sensitivity to cisplatin in non-small cell lung cancer cells. Patel NH; Xu J; Saleh T; Wu Y; Lima S; Gewirtz DA Biochem Pharmacol; 2020 May; 175():113896. PubMed ID: 32135156 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]